EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische StudieOpen Access

Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation

Hui Li iD, Ruyi Zou iD, Hongxia Xin iD, Ping He iD, Bin Xi iD, Yaqiong Tian iD, Qi Zhao iD, Xin Yan iD, Xiaohua Qiu iD, Yujuan Gao iD, Yin Liu iD, Min Cao iD und 5 weitere

Journal of Medical Internet Research · 05.02.2025 · 27 · e62836

DOI: 10.2196/62836 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Medical Internet Research, online erschienen am 05.02.2025. Verfasst von Hui Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing…. Hauptthemen laut MEDLINE: Dermatomyositis, Lung Diseases, Interstitial, Algorithms, Interferon-Induced Helicase, IFIH1. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with antimelanoma differentiation–associated gene 5 antibody–positive dermatomyositis–associated interstitial lung disease (anti-MDA5+DM-ILD) are susceptible to rapidly progressive interstitial lung disease (RP-ILD) and have a high risk of mortality. There is an urgent need for a reliable prediction model, accessible via an easy-to-use web-based tool, to evaluate the risk of death.

Objective

This study aimed to develop and validate a risk prediction model of 3-month mortality using machine learning (ML) in a large multicenter cohort of patients with anti-MDA5+DM-ILD in China.

Methods

In total, 609 consecutive patients with anti-MDA5+DM-ILD were retrospectively enrolled from 6 hospitals across China. Patient demographics and laboratory and clinical parameters were collected on admission. The primary endpoint was 3-month mortality due to all causes. Six ML algorithms (Extreme Gradient Boosting [XGBoost], logistic regression (LR), Light Gradient Boosting Machine [LightGBM], random forest [RF], support vector machine [SVM], and k-nearest neighbor [KNN]) were applied to construct and evaluate the model.

Results

After applying inclusion and exclusion criteria, 509 (83.6%) of the 609 patients were included in our study, divided into a training cohort (n=203, 39.9%), an internal validation cohort (n=51, 10%), and 2 external validation cohorts (n=92, 18.1%, and n=163, 32%). ML identified 8 important variables as critical for model construction: RP-ILD, erythrocyte sedimentation rate (ESR), serum albumin (ALB) level, age, C-reactive protein (CRP) level, aspartate aminotransferase (AST) level, lactate dehydrogenase (LDH) level, and the neutrophil-to-lymphocyte ratio (NLR). LR was chosen as the best algorithm for model construction, and the model demonstrated excellent performance, with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.866, a sensitivity of 84.8%, and a specificity of 84.4% on the validation data set and an AUC of 0.90, a sensitivity of 85.0%, and a specificity of 83.9% on the training data set. Calibration curves and decision curve analysis (DCA) confirmed the model’s accuracy and clinical applicability. Moreover, the model showed strong predictive performance in the external validation cohorts (cohort 1: AUC=0.836, 95% CI 0.754-0.916; cohort 2: AUC=0.915, 95% CI 0.871-0.959), indicating good generalizability. This model was integrated into a web-based tool to predict the 3-month mortality for patients with anti-MDA5+DM-ILD.

Conclusions

We successfully developed a robust clinical prediction model and an accompanying web tool to estimate the 3-month mortality risk for patients with anti-MDA5+DM-ILD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatomyositisLung Diseases, InterstitialAlgorithmsInterferon-Induced Helicase, IFIH1HumansMaleFemaleMiddle AgedRetrospective StudiesAgedChinaMachine LearningAdultRisk Assessment

Stichwörter der Autor:innen

3-month mortalityMLantimelanoma differentiation–associated gene 5 antibodyclinical outcomedermatomyositisidiopathic inflammatory myopathyimaginginterstitial lung diseaselung diseasemachine learningmelanomamortalitymyopathytoolweb based

Substanzen

Interferon-Induced Helicase, IFIH1IFIH1 protein, human

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Pulmonary and Critical Care Medicine, Seventh Affiliated Hospital, Sun Yatsen University, Shenzhen, China.
  • Department of Pulmonary and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
  • Department of Respiratory and Critical Care Medicine, Third People's Hospital of Chengdu, Chengdu, China.
  • Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Hui Li, Ruyi Zou, Hongxia Xin, Ping He, Bin Xi, Yaqiong Tian, Qi Zhao, Xin Yan, Xiaohua Qiu, Yujuan Gao, Yin Liu, Min Cao, Bi Chen, Qian Han, Juan Chen, Guochun Wang, Hourong Cai

Zitieren

APA

Li, H., Zou, R., Xin, H., He, P., Xi, B., Tian, Y., Zhao, Q., Yan, X., Qiu, X., Gao, Y., Liu, Y., Cao, M., Chen, B., Han, Q., Chen, J., Wang, G., & Cai, H. (2025). Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation. Journal of Medical Internet Research, 27, e62836. https://doi.org/10.2196/62836

Vancouver

Li H, Zou R, Xin H, He P, Xi B, Tian Y, et al. Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation. Journal of Medical Internet Research. 2025;27:e62836. doi:10.2196/62836

BibTeX
@article{Li2025,
  author = {Li, Hui and Zou, Ruyi and Xin, Hongxia and He, Ping and Xi, Bin and Tian, Yaqiong and Zhao, Qi and Yan, Xin and Qiu, Xiaohua and Gao, Yujuan and Liu, Yin and Cao, Min and Chen, Bi and Han, Qian and Chen, Juan and Wang, Guochun and Cai, Hourong},
  title = {Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e62836},
  doi = {10.2196/62836}
}
Kostenlos starten →